Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £239.60m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

AGM Trading Update

16 Jun 2020 07:00

RNS Number : 0104Q
Science Group PLC
16 June 2020
 

 

 

16 June 2020

 

 

 

 

 

Science Group plc

(the "Company" or "Science Group")

 

 

AGM Trading Update

 

 

At the Annual General Meeting of the Company to be held this morning, Martyn Ratcliffe, Executive Chairman, will provide the following update on trading.

 

"The Board is pleased to reaffirm that the performance of the Group in the year to date has been strong, despite the challenges posed by the Covid-19 pandemic. As a result, it is anticipated that Group adjusted operating profit for the first half of 2020 will be approximately 50% higher than reported in the same period of the prior year. Gross cash at 29 May 2020 was £21.6 million with net funds of £4.1 million.

 

This resilient performance has been achieved through a combination of organic growth in the Group's services operations and the contribution from the restructured Frontier Smart Technologies business, acquired in 2019.

 

In terms of the Group's services businesses, both the R&D Consultancy and Regulatory & Compliance Divisions have recorded revenue growth and increased profit contribution. While some business sectors have understandably been impacted by Covid-19, this has been more than offset by demand in other areas, with the Medical sector and the US regulatory operations performing particularly well compared to prior year.

 

As anticipated, revenue from the Frontier business has been impacted by the market contraction related to the pandemic, although we believe that the business' substantial market share (estimated at 70-80%) has been maintained and that its second half revenue will begin to recover as retail outlets across Europe reopen. Furthermore, it is particularly pleasing to report that even at this lower revenue, Frontier has traded profitably, confirming the success of the rapid post-acquisition integration programme implemented before the outbreak of Covid-19 and providing confidence in the future potential of the business.

 

In summary, while the future global economic impact resulting from the pandemic remains unclear and the Board therefore remains cautious, the strong first half performance provides an excellent platform for the year as a whole. This enables the Group to continue to invest in future organic growth and explore further acquisition opportunities."

 

 

End

 

Science Group plc

Martyn Ratcliffe, Chairman

Tel: +44 (0) 1223 875 200

Rebecca Archer, Finance Director

www.sciencegroup.com

Panmure Gordon

Nominated Adviser: Dominic Morley, Alina Vaskina

Tel: +44 (0) 20 7886 2500

Corporate Broking: Erik Anderson

MHP Communications (PR Advisor to Science Group)

Reg Hoare, James Bavister, Pete Lambie

Tel: +44 (0) 20 3128 8100

sciencegroup@mhpc.com

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation (No 596/2014).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEELFFBQLFBBL
Date   Source Headline
11th Jun 20267:00 amRNSTransaction in Own Shares
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:01 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTreasury shares issued
1st Jun 20267:00 amRNSTotal Voting Rights
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:01 amRNSTransaction in Own Shares
27th May 20267:00 amRNSIssue of share options and PDMR dealing
22nd May 20267:00 amRNSTreasury Shares Issued
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20261:05 pmRNSResult of Annual General Meeting
20th May 20267:01 amRNSAGM Trading Update and Capital Allocation
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:01 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTreasury Shares Issued
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:01 amRNSNotice of Annual General Meeting
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTreasury Shares Issued
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.